AMRN
HEALTHCAREAmarin Corp
$14.90+0.40 (+2.76%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AMRN Today?
No stock-specific AI insight has been generated for AMRN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$9.98$20.90
$14.90
Fundamentals
Market Cap$312M
P/E Ratio—
EPS$-1.60
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume60K
Avg Volume (10D)—
Shares Outstanding21.0M
AMRN News
20 articles- Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater ChinaYahoo Finance·May 7, 2026
- ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View DownYahoo Finance·May 7, 2026
- TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 ViewYahoo Finance·May 7, 2026
- UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong OutlookYahoo Finance·May 7, 2026
- Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock RisesYahoo Finance·May 6, 2026
- Repligen's Q1 Earnings & Revenues Beat Estimates, Stock RisesYahoo Finance·May 6, 2026
- VRTX's Q1 Earnings Beat Estimates, New Products Aid Sales GrowthYahoo Finance·May 5, 2026
- All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong BuyYahoo Finance·May 5, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week LowerYahoo Finance·May 4, 2026
- CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook RaisedYahoo Finance·May 1, 2026
- European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for WeekYahoo Finance·May 1, 2026
- Amarin's Q1 Loss Narrower Than Expected, Sales Increase Y/YYahoo Finance·Apr 30, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Thursday TradingYahoo Finance·Apr 30, 2026
- Amarin Corp PLC (AMRN) Q1 2026 Earnings Call Highlights: Revenue Growth and Market Expansion ...Yahoo Finance·Apr 30, 2026
- Amarin Q1 Earnings Call HighlightsMarketbeat·Apr 29, 2026
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth StrategyAdvfn·Apr 29, 2026
- Amarin Reports 2026 First Quarter Financial ResultsYahoo Finance·Apr 29, 2026
- How The Amarin (AMRN) Story Is Shifting With An Unchanged US$12 Fair ValueYahoo Finance·Apr 25, 2026
- European Equities Traded in US as ADRs Ease in Thursday TradingYahoo Finance·Apr 23, 2026
- Has Amarin (AMRN) Outpaced Other Medical Stocks This Year?Yahoo Finance·Apr 23, 2026
All 20 articles loaded
Price Data
Open$13.87
Previous Close$14.50
Day High$14.23
Day Low$12.96
52 Week High$20.90
52 Week Low$9.98
52-Week Range
$9.98$20.90
$14.90
Fundamentals
Market Cap$312M
P/E Ratio—
EPS$-1.60
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume60K
Avg Volume (10D)—
Shares Outstanding21.0M
About Amarin Corp
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
HEALTHCAREDRUG MANUFACTURERS - GENERAL
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - GENERAL
CIK—
Composite FIGI—
Share Class FIGI—